Insulin-like growth factor I and II binding in human myometrium and leiomyomas

Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):64-9. doi: 10.1016/0002-9378(92)91831-t.

Abstract

Objectives: The purpose of this study is to determine if the human myometrium has receptors for insulin-like growth factors I and II and whether the concentration of these receptors is increased in leiomyomas.

Study design: Specific binding of iodine 125-labeled insulin-like growth factor I and II was examined in the membrane preparations of myometrium and leiomyomas obtained from 10 women with uterine leiomyomas.

Results: Binding studies indicate presence of specific binding sites for both insulin-like growth factors I and II in the myometrium and leiomyoma. The concentration of binding sites for insulin-like growth factor I, but not for insulin-like growth factor II, was significantly (p less than 0.01) higher in leiomyomas than in the myometrium. The dissociation constants for insulin-like growth factors I and II receptors in both myometrium and leiomyoma were similar.

Conclusion: insulin-like growth factor I, but not insulin-like growth factor II, receptors are increased in leiomyomas compared with those in myometrium, indicating that insulin-like growth factor I may play a role in the generation and/or growth of this tumor.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Cell Membrane / metabolism
  • Female
  • Humans
  • Insulin-Like Growth Factor I / metabolism*
  • Insulin-Like Growth Factor II / metabolism*
  • Leiomyoma / metabolism*
  • Middle Aged
  • Myometrium / metabolism*
  • Receptors, Cell Surface / metabolism*
  • Receptors, Somatomedin
  • Uterine Neoplasms / metabolism*

Substances

  • Receptors, Cell Surface
  • Receptors, Somatomedin
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II